CoQ10 is widely promoted on social media as a remedy for statin-related muscle pain, but clinical evidence remains mixed.

A two-cohort observational study found statin users had roughly doubled dementia hazard after weighting-based adjustment, ...

The European Medicines Agency (EMA) has validated two marketing authorization applications (MAA) from Daiichi Sankyo (TSE: 4568) for oral, single-pill triple-combination therapies. The applications ...

Cholesterol drugs do more than move numbers. This deep dive into bempedoic acid explores a newly discovered PPARα mechanism, ...

Drs Lisa VanWagner and Kathleen Corey examine how MASLD should shape cardiovascular risk assessment, statin use, and treatment decisions.

Polymyalgia RheumaticaESR and CRPLab Interpretation Yes—blood results can be normal in polymyalgia rheumatica, although ...

Federal HIV guidelines add Bixlenvo as a switch option, back statins for adults 40 to 75 and urge clinicians to challenge payer barriers to antiretroviral therapy (ART).

Matthew Nudy, MD, on estrogen's cardiovascular effects, risk assessment, and hormone therapy safety in younger menopausal ...

A new narrative review describes how 2026 lipid guidelines shift ASCVD prevention toward lifetime risk models, ...

Sjögren's disease is a systemic autoimmune disease that can affect the entire body. Along with symptoms of extensive dryness, other serious manifestations may include profound fatigue, chronic pain, ...

The US FDA approved Lipfendra, the first oral PCSK9 inhibitor to lower LDL cholesterol in adults with high cholesterol, ...

Daiichi Sankyo submitted two marketing authorization applications to the European Medicines Agency for oral, single-pill triple-combination therapies. The applications seek approval for the treatment ...